美国2018年13-17岁青少年疫苗接种覆盖率
CDC分析2018年NIS-Teen调查中18,700名13-17岁青少年数据,评估美国青少年疫苗接种覆盖率。2017-2018年,HPV疫苗≥1剂覆盖率从65.5%升至68.1%,系列完成率从48.6%升至51.1%,但增幅仅见于男性;MenACWY≥1剂和≥2剂覆盖率分别从85.1%升至86.6%、从44.3%升至50.8%;Tdap稳定在89%。地区与保险状态差异持续存在。
要点
- HPV疫苗覆盖率上升但仅见于男性,系列完成率51.1%。
- MenACWY≥2剂覆盖率从44.3%升至50.8%,Tdap稳定在89%。
- 父母报告接种推荐的比例各州差异大(60%-91%)。
核心结论
- 2017-2018年美国青少年HPV疫苗、MenACWY接种覆盖率有所上升,但HPV疫苗增幅仅见于男性,Tdap覆盖率稳定。
- 地区与保险状态相关的接种差异持续存在,提供者推荐对HPV疫苗接种覆盖率有影响。
研究设计与样本
- CDC分析2018年NIS-Teen调查数据,纳入18,700名13-17岁青少年。
主要发现
- HPV疫苗≥1剂覆盖率从65.5%升至68.1%,系列完成率从48.6%升至51.1%,增幅仅见于男性。
- MenACWY≥1剂覆盖率从85.1%升至86.6%,≥2剂覆盖率从44.3%升至50.8%。
- Tdap覆盖率稳定在89%。
- 父母报告接种推荐的比例各州范围60%-91%,HPV疫苗覆盖率在报告收到推荐者中更高。
关键数值与推荐
- ACIP推荐11-12岁常规接种HPV疫苗、MenACWY和Tdap;16岁推荐MenACWY加强剂;MenB可于16-23岁接种。
临床怎么用
- 支持提供者给出强力推荐并有效回应家长顾虑,尤其在推荐报告率较低的州和农村地区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of persons aged 11-12 years to protect against certain diseases, including human papillomavirus (HPV)-associated cancers, meningococcal disease, and pertussis (1). A booster dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended at age 16 years, and serogroup B meningococcal vaccine (MenB) may be administered to persons aged 16-23 years (1). To estimate vaccination coverage among adolescents in the United States, CDC analyzed data from the 2018 National Immunization Survey-Teen (NIS-Teen) which included 18,700 adolescents aged 13-17 years.* During 2017-2018, coverage with ≥1 dose of HPV vaccine increased from 65.5% to 68.1%, and the percentage of adolescents up-to-date† with the HPV vaccine series increased from 48.6% to 51.1%, although the increases were only observed among males. Vaccination coverage increases were also observed for ≥1 MenACWY dose (from 85.1% to 86.6%) and ≥2 MenACWY doses (from 44.3% to 50.8%). Coverage with tetanus and reduced diphtheria toxoids and acellular pertussis vaccine (Tdap) remained stable at 89%. Disparities in coverage by metropolitan statistical area (MSA)§ and health insurance status identified in previous years persisted (2). Coverage with ≥1 dose of HPV vaccine was higher among adolescents whose parents reported receiving a provider recommendation; however, prevalence of parents reporting receiving a recommendation for adolescent HPV vaccination varied by state (range = 60%-91%). Supporting providers to give strong recommendations and effectively address parental concerns remains a priority, especially in states and rural areas where provider recommendations were less commonly reported.
引用
- Walker TY, Elam-Evans LD, Yankey D, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31437143. doi:10.15585/mmwr.mm6833a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。